<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Can Acad Child Adolesc Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">J Can Acad Child Adolesc Psychiatry</journal-id>
<journal-id journal-id-type="publisher-id">101280868</journal-id>
<journal-title-group>
<journal-title>Journal of the Canadian Academy of Child and Adolescent Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1719-8429</issn>
<publisher>
<publisher-name>Canadian Academy of Child and Adolescent Psychiatry</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29056983</article-id>
<article-id pub-id-type="pmc">5642460</article-id>
<article-id pub-id-type="publisher-id">ccap26_p0205</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glutamate Genetics in Obsessive-Compulsive Disorder: A Review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rajendram</surname>
<given-names>Rageen</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="af1-ccap26_p0205">1</xref>
<xref ref-type="corresp" rid="c1-ccap26_p0205"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kronenberg</surname>
<given-names>Sefi</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="af2-ccap26_p0205">2</xref>
<xref ref-type="aff" rid="af3-ccap26_p0205">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burton</surname>
<given-names>Christie L.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="af4-ccap26_p0205">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arnold</surname>
<given-names>Paul D.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="af4-ccap26_p0205">4</xref>
<xref ref-type="aff" rid="af5-ccap26_p0205">5</xref>
</contrib>
</contrib-group>
<aff id="af1-ccap26_p0205">
<label>1</label>University of Toronto, Faculty of Medicine, Toronto, Ontario</aff>
<aff id="af2-ccap26_p0205">
<label>2</label>Department of Psychiatry, University of Toronto, Toronto, Ontario</aff>
<aff id="af3-ccap26_p0205">
<label>3</label>Department of Psychiatry, The Hospital for Sick Children, Toronto, Ontario</aff>
<aff id="af4-ccap26_p0205">
<label>4</label>Genetics &amp; Genome Biology, The Hospital for Sick Children; Toronto, Ontario</aff>
<aff id="af5-ccap26_p0205">
<label>5</label>Mathison Centre for Mental Health Research &amp; Education, Cumming School of Medicine, University of Calgary, Calgary, Alberta</aff>
<author-notes>
<corresp id="c1-ccap26_p0205">Corresponding E-Mail: <email>rageen@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<season>Fall</season>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>1</day>
<month>10</month>
<year>2017</year>
</pub-date>
<volume>26</volume>
<issue>3</issue>
<fpage>205</fpage>
<lpage>213</lpage>
<history>
<date date-type="received">
<day>18</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Canadian Academy of Child and Adolescent Psychiatry</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>Obsessive-compulsive disorder (OCD) is common and debilitating with patients exhibiting persistent intrusive thoughts (obsessions), repetitive ritualistic behaviours (compulsions) and anxiety. While it is known that OCD is highly heritable, the specific genetic risk factors for OCD are still largely unknown. The etiology of OCD has also not been fully elucidated but there is growing evidence that glutamate signaling dysfunction in the cortico-striatal-thalamo-cortical (CSTC) circuitry plays a role in its pathogenesis.</p>
</sec>
<sec>
<title>Methods</title>
<p>We conducted a focused review of recent literature on the role of glutamate genes in OCD.</p>
</sec>
<sec>
<title>Results</title>
<p>There have been several recent discoveries in the SAPAP (DLGAP) family, SLC1A1, and GRIN/GRIK families of proteins related to OCD.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>There is growing evidence supporting a role for genetic variation leading to dysfunctional glutamate signaling in OCD. Based on this new evidence we hypothesize that sustained glutamatergic neurotransmission in key areas of the brain may be contributing to the etiology of OCD.</p>
</sec>
</abstract>
<trans-abstract xml:lang="fr">
<title>Résumé</title>
<sec>
<title>Objectif</title>
<p>Le trouble obsessionnel-compulsif (TOC) est commun et débilitant chez les patients qui présentent des pensées intrusives (obsessions) persistantes, des comportements rituels répétitifs (compulsions) et de l’anxiété. Bien que l’on sache que le TOC est fortement héréditaire, les facteurs de risque génétique spécifiques du TOC sont encore largement inconnus. L’étiologie du TOC n’a pas non plus été encore pleinement élucidée, mais il apparaît de plus en plus que le glutamate qui signale une dysfonction dans le circuit cortico-striatal-thalamo-cortical (CSTC) joue un rôle dans sa pathogenèse.</p>
</sec>
<sec>
<title>Méthodes</title>
<p>Nous avons mené une revue ciblée de la littérature récente sur le rôle des gènes du glutamate dans le TOC.</p>
</sec>
<sec>
<title>Résultats</title>
<p>Il y a eu plusieurs découvertes récentes dans la famille SAPAP (DLGAP), les familles de protéines SLC1A1, et GRIN/GRIK liées au TOC.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Les preuves s’accumulent à l’appui du rôle d’une variation génétique menant à un signal dysfonctionnel du glutamate dans le TOC. Selon ces nouvelles preuves, nous émettons l’hypothèse que la neurotransmission glutamatergique soutenue dans les principales régions du cerveau peut contribuer à l’étiologie du TOC.</p>
</sec>
</trans-abstract>
<kwd-group>
<kwd>OCD</kwd>
<kwd>glutamate</kwd>
<kwd>genetics</kwd>
</kwd-group>
<kwd-group xml:lang="fr">
<title>Mots clés</title>
<kwd>TOC</kwd>
<kwd>glutamate</kwd>
<kwd>génétique</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>